Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Globus Medical (GMED) witnesses around $20 million of COVID-19 related adverse impact on its Q1 sales.
Wall Street securities analysts on Friday revised their ratings and price targets on several U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings. HIGHLIGHTS

Why Globus Medical Missed Q1 Estimates

11:00am, Friday, 08'th May 2020
Yes, it's been a rough year for Globus Medical (NYSE: GMED). Globus announced its first-quarter results after the market closed on Thursday. Globus Medical reported first-quarter revenue of $190.6
Q1 2020 Globus Medical Inc Earnings Call
Globus Medical (GMED) delivered earnings and revenue surprises of -27.50% and -4.65%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE